Korean J Urol.  2014 Apr;55(4):228-238. 10.4111/kju.2014.55.4.228.

Treatment of Bladder Dysfunction Using Stem Cell or Tissue Engineering Technique

• Kim JH
• Lee HJ
• Song YS

• KMID: 1885602
• DOI: http://doi.org/10.4111/kju.2014.55.4.228

Abstract

Tissue engineering and stem cell transplantation are two important options that may help overcome limitations in the current treatment strategy for bladder dysfunction. Stem cell therapy holds great promise for treating pathophysiology, as well as for urological tissue engineering and regeneration. To date, stem cell therapy in urology has mainly focused on oncology and erectile dysfunction. The therapeutic potency of stem cells (SCs) was originally thought to derive from their ability to differentiate into various cell types including smooth muscle. The main mechanisms of SCs in reconstituting or restoring bladder function are migration, differentiation, and paracrine effects. Nowadays, paracrine effects of stem cells are thought to be more prominent because of their stimulating effects on stem cells and adjacent cells. Studies of stem cell therapy for bladder dysfunction have been limited to experimental models and have been less focused on tissue engineering for bladder regeneration. Bladder outlet obstruction is a representative model. Adipose-derived stem cells, bone marrow stem cells (BMSCs), and skeletal muscle-derived stem cells or muscle precursor cells are used for transplantation to treat bladder dysfunction. The aim of this study is to review stem cell therapy and updated tissue regeneration as treatments for bladder dysfunction and to provide the current status of stem cell therapy and tissue engineering for bladder dysfunction including its mechanisms and limitations.

Keyword

Overactive urinary bladder; Stem cells; Urinary bladder; Urinary bladder neck obstruction

MeSH Terms

Bone Marrow
Erectile Dysfunction
Male
Models, Theoretical
Muscle, Smooth
Regeneration
Stem Cell Transplantation
Stem Cells*
Tissue Engineering*
Urinary Bladder Neck Obstruction
Urinary Bladder*
Urinary Bladder, Overactive
Urology

Reference

1. Masters JR, Kane C, Yamamoto H, Ahmed A. Prostate cancer stem cell therapy: hype or hope? Prostate Cancer Prostatic Dis. 2008; 11:316–319. PMID: 18427568.

2. Stanasel I, Mirzazadeh M, Smith JJ 3rd. Bladder tissue engineering. Urol Clin North Am. 2010; 37:593–599. PMID: 20955910.

3. Li JH, Zhang N, Wang JA. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J Endocrinol Invest. 2008; 31:103–110. PMID: 18362500.

4. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004; 40:1304–1311. PMID: 15565662.

5. Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN, et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol. 2005; 11:3431–3440. PMID: 15948250.

6. Bongso A, Fong CY, Gauthaman K. Taking stem cells to the clinic: major challenges. J Cell Biochem. 2008; 105:1352–1360. PMID: 18980213.

7. Choumerianou DM, Dimitriou H, Kalmanti M. Stem cells: promises versus limitations. Tissue Eng Part B Rev. 2008; 14:53–60. PMID: 18454634.

8. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007; 9:204. PMID: 17316462.

9. Kim JH, Lee SR, Song YS, Lee HJ. Stem cell therapy in bladder dysfunction: where are we? And where do we have to go? Biomed Res Int. 2013; 2013:930713. PMID: 24151627.

10. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418:41–49. PMID: 12077603.

11. Furuta A, Carr LK, Yoshimura N, Chancellor MB. Advances in the understanding of sress urinary incontinence and the promise of stem-cell therapy. Rev Urol. 2007; 9:106–112. PMID: 17934567.

12. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A. 2000; 97:3213–3218. PMID: 10725391.

13. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284:143–147. PMID: 10102814.

14. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001; 98:2396–2402. PMID: 11588036.

15. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002; 106:1913–1918. PMID: 12370212.

16. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001; 7:211–228. PMID: 11304456.

17. Lin G, Garcia M, Ning H, Banie L, Guo YL, Lue TF, et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008; 17:1053–1063. PMID: 18597617.

18. Albersen M, Fandel TM, Lin G, Wang G, Banie L, Lin CS, et al. Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med. 2010; 7:3331–3340. PMID: 20561166.

19. Huang YC, Ning H, Shindel AW, Fandel TM, Lin G, Harraz AM, et al. The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J Sex Med. 2010; 7(4 Pt 1):1391–1400. PMID: 20141586.

20. Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Ther. 2002; 9:642–647. PMID: 12032710.

21. Nitta M, Tamaki T, Tono K, Okada Y, Masuda M, Akatsuka A, et al. Reconstitution of experimental neurogenic bladder dysfunction using skeletal muscle-derived multipotent stem cells. Transplantation. 2010; 89:1043–1049. PMID: 20150836.

22. Yokoyama T, Huard J, Pruchnic R, Yoshimura N, Qu Z, Cao B, et al. Muscle-derived cell transplantation and differentiation into lower urinary tract smooth muscle. Urology. 2001; 57:826–831. PMID: 11306423.

23. Lu SH, Cannon TW, Chermanski C, Pruchnic R, Somogyi G, Sacks M, et al. Muscle-derived stem cells seeded into acellular scaffolds develop calcium-dependent contractile activity that is modulated by nicotinic receptors. Urology. 2003; 61:1285–1291. PMID: 12809930.

24. Kwon D, Minnery B, Kim Y, Kim JH, de Miguel F, Yoshimura N, et al. Neurologic recovery and improved detrusor contractility using muscle-derived cells in rat model of unilateral pelvic nerve transection. Urology. 2005; 65:1249–1253. PMID: 15922415.

25. Tamaki T, Okada Y, Uchiyama Y, Tono K, Masuda M, Wada M, et al. Synchronized reconstitution of muscle fibers, peripheral nerves and blood vessels by murine skeletal muscle-derived CD34(-)/45(-) cells. Histochem Cell Biol. 2007; 128:349–360. PMID: 17762938.

26. Tamaki T, Uchiyama Y, Okada Y, Ishikawa T, Sato M, Akatsuka A, et al. Functional recovery of damaged skeletal muscle through synchronized vasculogenesis, myogenesis, and neurogenesis by muscle-derived stem cells. Circulation. 2005; 112:2857–2866. PMID: 16246946.

27. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008; 3:301–313. PMID: 18786417.

28. Amos PJ, Mulvey CL, Seaman SA, Walpole J, Degen KE, Shang H, et al. Hypoxic culture and in vivo inflammatory environments affect the assumption of pericyte characteristics by human adipose and bone marrow progenitor cells. Am J Physiol Cell Physiol. 2011; 301:C1378–C1388. PMID: 21865587.

29. Bharadwaj S, Liu G, Shi Y, Wu R, Yang B, He T, et al. Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells. 2013; 31:1840–1856. PMID: 23666768.

30. Estes BT, Wu AW, Guilak F. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum. 2006; 54:1222–1232. PMID: 16572454.

31. Silva WA Jr, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells. 2003; 21:661–669. PMID: 14595126.

32. Zubko R, Frishman W. Stem cell therapy for the kidney? Am J Ther. 2009; 16:247–256. PMID: 19092639.

33. Sharma AD, Cantz T, Manns MP, Ott M. The role of stem cells in physiology, pathophysiology, and therapy of the liver. Stem Cell Rev. 2006; 2:51–58. PMID: 17142887.

34. Hsiao ST, Asgari A, Lokmic Z, Sinclair R, Dusting GJ, Lim SY, et al. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev. 2012; 21:2189–2203. PMID: 22188562.

35. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A. 2003; 100:8407–8411. PMID: 12815096.

36. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol. 2004; 36:585–597. PMID: 15010325.

37. Sundararaman S, Miller TJ, Pastore JM, Kiedrowski M, Aras R, Penn MS. Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Ther. 2011; 18:867–873. PMID: 21472007.

38. Chamberlain G, Wright K, Rot A, Ashton B, Middleton J. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One. 2008; 3:e2934. PMID: 18698345.

39. Abdel Aziz MT, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Ahmed HH, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem. 2007; 40:893–899. PMID: 17543295.

40. Lee HJ, Won JH, Doo SH, Kim JH, Song KY, Lee SJ, et al. Inhibition of collagen deposit in obstructed rat bladder outlet by transplantation of superparamagnetic iron oxide-labeled human mesenchymal stem cells as monitored by molecular magnetic resonance imaging (MRI). Cell Transplant. 2012; 21:959–970. PMID: 22449414.

41. Song YS, Lee HJ, Doo SH, Lee SJ, Lim I, Chang KT, et al. Mesenchymal stem cells overexpressing hepatocyte growth factor (HGF) inhibit collagen deposit and improve bladder function in rat model of bladder outlet obstruction. Cell Transplant. 2012; 21:1641–1650. PMID: 22506988.

42. Woo LL, Tanaka ST, Anumanthan G, Pope JC 4th, Thomas JC, Adams MC, et al. Mesenchymal stem cell recruitment and improved bladder function after bladder outlet obstruction: preliminary data. J Urol. 2011; 185:1132–1138. PMID: 21255803.

43. Vaegler M, Lenis AT, Daum L, Amend B, Stenzl A, Damaser MS, et al. Stem cell therapy for voiding and erectile dysfunction. Nat Rev Urol. 2012; 6. 19. [Epub]. http://dx.doi.org/10.1038/nrurol.2012.111.

44. Hammerick KE, Longaker MT, Prinz FB. In vitro effects of direct current electric fields on adipose-derived stromal cells. Biochem Biophys Res Commun. 2010; 397:12–17. PMID: 20452327.

45. Li L, El-Hayek YH, Liu B, Chen Y, Gomez E, Wu X, et al. Direct-current electrical field guides neuronal stem/progenitor cell migration. Stem Cells. 2008; 26:2193–2200. PMID: 18556511.

46. Zhang J, Calafiore M, Zeng Q, Zhang X, Huang Y, Li RA, et al. Electrically guiding migration of human induced pluripotent stem cells. Stem Cell Rev. 2011; 7:987–996. PMID: 21373881.

47. Rando TA. The immortal strand hypothesis: segregation and reconstruction. Cell. 2007; 129:1239–1243. PMID: 17604710.

48. Jack GS, Zhang R, Lee M, Xu Y, Wu BM, Rodriguez LV. Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials. 2009; 30:3259–3270. PMID: 19345408.

49. Shukla D, Box GN, Edwards RA, Tyson DR. Bone marrow stem cells for urologic tissue engineering. World J Urol. 2008; 26:341–349. PMID: 18654786.

50. Drost AC, Weng S, Feil G, Schafer J, Baumann S, Kanz L, et al. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair. Ann N Y Acad Sci. 2009; 1176:135–143. PMID: 19796241.

51. Anumanthan G, Makari JH, Honea L, Thomas JC, Wills ML, Bhowmick NA, et al. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol. 2008; 180(4 Suppl):1778–1783. PMID: 18721942.

52. Tian H, Bharadwaj S, Liu Y, Ma PX, Atala A, Zhang Y. Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng Part A. 2010; 16:1769–1779. PMID: 20020816.

53. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004; 84:767–801. PMID: 15269336.

54. Zhang R, Jack GS, Rao N, Zuk P, Ignarro LJ, Wu B, et al. Nuclear fusion-independent smooth muscle differentiation of human adipose-derived stem cells induced by a smooth muscle environment. Stem Cells. 2012; 30:481–490. PMID: 22213158.

55. Alexanian AR, Kurpad SN. Quiescent neural cells regain multipotent stem cell characteristics influenced by adult neural stem cells in co-culture. Exp Neurol. 2005; 191:193–197. PMID: 15589526.

56. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 1995; 373:699–702. PMID: 7854452.

57. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 2004; 109:1543–1549. PMID: 15023891.

58. Matsuda-Hashii Y, Takai K, Ohta H, Fujisaki H, Tokimasa S, Osugi Y, et al. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Exp Hematol. 2004; 32:955–961. PMID: 15504551.

59. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2010; 86:588–610.

60. Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A. 2006; 103:1283–1288. PMID: 16432190.

61. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008; 26:2287–2299. PMID: 18566331.

62. Chung SY, Krivorov NP, Rausei V, Thomas L, Frantzen M, Landsittel D, et al. Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J Urol. 2005; 174:353–359. PMID: 15947689.

63. Frimberger D, Morales N, Shamblott M, Gearhart JD, Gearhart JP, Lakshmanan Y. Human embryoid body-derived stem cells in bladder regeneration using rodent model. Urology. 2005; 65:827–832. PMID: 15833555.

64. Zhang Y, Lin HK, Frimberger D, Epstein RB, Kropp BP. Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int. 2005; 96:1120–1125. PMID: 16225540.

65. Drewa T, Joachimiak R, Kaznica A, Sarafian V, Pokrywczynska M. Hair stem cells for bladder regeneration in rats: preliminary results. Transplant Proc. 2009; 41:4345–4351. PMID: 20005396.

66. Zhu WD, Xu YM, Feng C, Fu Q, Song LJ, Cui L. Bladder reconstruction with adipose-derived stem cell-seeded bladder acellular matrix grafts improve morphology composition. World J Urol. 2010; 28:493–498. PMID: 20091038.

67. Sharma AK, Hota PV, Matoka DJ, Fuller NJ, Jandali D, Thaker H, et al. Urinary bladder smooth muscle regeneration utilizing bone marrow derived mesenchymal stem cell seeded elastomeric poly(1,8-octanediol-co-citrate) based thin films. Biomaterials. 2010; 31:6207–6217. PMID: 20488535.

68. Tian H, Bharadwaj S, Liu Y, Ma H, Ma PX, Atala A, et al. Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials. 2010; 31:870–877. PMID: 19853294.

69. Sakuma T, Matsumoto T, Kano K, Fukuda N, Obinata D, Yamaguchi K, et al. Mature, adipocyte derived, dedifferentiated fat cells can differentiate into smooth muscle-like cells and contribute to bladder tissue regeneration. J Urol. 2009; 182:355–365. PMID: 19457498.

70. Lai JY, Yoon CY, Yoo JJ, Wulf T, Atala A. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol. 2002; 168(4 Pt 2):1853–1857. PMID: 12352375.

71. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006; 367:1241–1246. PMID: 16631879.

72. Subramaniam R, Hinley J, Stahlschmidt J, Southgate J. Tissue engineering potential of urothelial cells from diseased bladders. J Urol. 2011; 186:2014–2020. PMID: 21944117.

73. Feil G, Christ-Adler M, Maurer S, Corvin S, Rennekampff HO, Krug J, et al. Investigations of urothelial cells seeded on commercially available small intestine submucosa. Eur Urol. 2006; 50:1330–1337. PMID: 16820260.

74. Sharma AK, Bury MI, Marks AJ, Fuller NJ, Meisner JW, Tapaskar N, et al. A nonhuman primate model for urinary bladder regeneration using autologous sources of bone marrow-derived mesenchymal stem cells. Stem Cells. 2011; 29:241–250. PMID: 21732482.

75. Valiunas V, Doronin S, Valiuniene L, Potapova I, Zuckerman J, Walcott B, et al. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol. 2004; 555(Pt 3):617–626. PMID: 14766937.

76. Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. IV. Bladder outlet obstruction. J Urol. 1993; 150(5 Pt 2):1681–1695. PMID: 8411456.

77. Steers WD, De Groat WC. Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J Urol. 1988; 140:864–871. PMID: 3418824.

78. Baskin LS, Sutherland RS, Thomson AA, Hayward SW, Cunha GR. Growth factors and receptors in bladder development and obstruction. Lab Invest. 1996; 75:157–166. PMID: 8765316.

79. Ghafar MA, Anastasiadis AG, Olsson LE, Chichester P, Kaplan SA, Buttyan R, et al. Hypoxia and an angiogenic response in the partially obstructed rat bladder. Lab Invest. 2002; 82:903–909. PMID: 12118092.

80. Levin RM, O'Connor LJ, Leggett RE, Whitbeck C, Chichester P. Focal hypoxia of the obstructed rabbit bladder wall correlates with intermediate decompensation. Neurourol Urodyn. 2003; 22:156–163. PMID: 12579634.

81. Nishijima S, Sugaya K, Miyazato M, Kadekawa K, Oshiro Y, Uchida A, et al. Restoration of bladder contraction by bone marrow transplantation in rats with underactive bladder. Biomed Res. 2007; 28:275–280. PMID: 18000341.

82. Huang YC, Shindel AW, Ning H, Lin G, Harraz AM, Wang G, et al. Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J Urol. 2010; 183:1232–1240. PMID: 20096880.

83. Tanaka ST, Martinez-Ferrer M, Makari JH, Wills ML, Thomas JC, Adams MC, et al. Recruitment of bone marrow derived cells to the bladder after bladder outlet obstruction. J Urol. 2009; 182(4 Suppl):1769–1774. PMID: 19692058.

84. Song M, Heo J, Chun JY, Bae HS, Kang JW, Kang H, et al. The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder. Stem Cells Dev. 2014; 23:654–663. PMID: 24192209.

85. Kucia M, Reca R, Campbell FR, Zuba-Surma E, Majka M, Ratajczak J, et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia. 2006; 20:857–869. PMID: 16498386.

86. Ratajczak MZ, Machalinski B, Wojakowski W, Ratajczak J, Kucia M. A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues. Leukemia. 2007; 21:860–867. PMID: 17344915.

87. Dissaranan C, Cruz MA, Couri BM, Goldman HB, Damaser MS. Stem cell therapy for incontinence: where are we now? What is the realistic potential? Curr Urol Rep. 2011; 12:336–344. PMID: 21842258.

88. Chen S, Zhang HY, Zhang N, Li WH, Shan H, Liu K, et al. Treatment for chronic ischaemia-induced bladder detrusor dysfunction using bone marrow mesenchymal stem cells: an experimental study. Int J Mol Med. 2012; 29:416–422. PMID: 22109789.

89. Azadzoi KM. Effect of chronic ischemia on bladder structure and function. Adv Exp Med Biol. 2003; 539(Pt A):271–280. PMID: 15088910.

90. Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007; 100:987–1006. PMID: 17922784.

91. Azadzoi KM, Tarcan T, Kozlowski R, Krane RJ, Siroky MB. Overactivity and structural changes in the chronically ischemic bladder. J Urol. 1999; 162:1768–1778. PMID: 10524933.

92. Zhang H, Qiu X, Shindel AW, Ning H, Ferretti L, Jin X, et al. Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model. Stem Cells Dev. 2012; 21:1391–1400. PMID: 22008016.

93. Lee JY, Piao S, Kim IG, Byun SS, Hwang JH, Hong SH, et al. Effect of human muscle-derived stem cells on cryoinjured mouse bladder contractility. Urology. 2012; 80:224.e7–224.e11. PMID: 22748891.

94. Christ GJ, Rehman J, Day N, Salkoff L, Valcic M, Melman A, et al. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol. 1998; 275(2 Pt 2):H600–H608. PMID: 9683449.

95. Hellweg R, Hartung HD. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res. 1990; 26:258–267. PMID: 2142224.

96. Morris BD Jr, Drazan KE, Csete ME, Werthman PE, Van Bree MP, Rosenthal JT, et al. Adenoviral-mediated gene transfer to bladder in vivo. J Urol. 1994; 152(2 Pt 1):506–509. PMID: 8015103.

97. Goins WF, Lee KA, Cavalcoli JD, O'Malley ME, DeKosky ST, Fink DJ, et al. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol. 1999; 73:519–532. PMID: 9847358.

98. Raivich G, Makwana M. The making of successful axonal regeneration: genes, molecules and signal transduction pathways. Brain Res Rev. 2007; 53:287–311. PMID: 17079020.

99. Tremp M, Salemi S, Largo R, Andersson KE, APlock J, Aboushwareb T, et al. Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunction. World J Urol. 2013; 11. 12. [Epub]. http://dx.doi.org/10.1007/s00345-013-1200-6.

100. Dayanc M, Kibar Y, Ural AU, Onguru O, Yildiz O, Irkilata HC, et al. The histopathologic, pharmacologic and urodynamic results of mesenchymal stem cell's injection into the decompensated rabbit's bladder. Stem Cell Rev. 2012; 8:1245–1253. PMID: 22736388.